EN
HI
Jagsonpal Pharmaceuticals share price chart
Jagsonpal Pharmaceuticals Share Key Metrics
Volume
50652.00
Market Cap
1520.73 CR
LTQ@LTP
46@230.99
ATP
231.15
Var Margin
20.42 %
Circuit Range
186.38-279.56
Delivery %
43.36 %
Value
1.17 CR
ASM/GSM
No
Market Lot
1
Summary
JAGSNPHARM stock price is ₹230.99 as of 11 Aug, 2026. The stock intraday movement has stayed between ₹229.99 and ₹234.10, while Jagsonpal Pharmaceuticals share price 52 week high low is ₹155.00 & ₹272.50.
In terms of trading activity, JAGSNPHARM share price has recorded a volume of 50,652 shares. The Jagsonpal Pharmaceuticals has a market cap of ₹65835470. The stock’s Average Traded Price (ATP) stands at ₹231.15, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 46 @ ₹230.99.
The Jagsonpal Pharmaceuticals upper circuit limit is ₹279.56 & The Jagsonpal Pharmaceuticals lower circuit limit is ₹186.38, with a Value of ₹1.17 CR. The Delivery Percentage for the day is 43.36%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Jagsonpal Pharmaceuticals Fundamentals
P/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
64.83
Sector P/B
3.28
Sec. Div. Yield
0.51
Jagsonpal Pharmaceuticals Resistance and Support
Pivot 232.7
Resistance
First Resistance
235.05
Second Resistance
237.14
Third Resistance
239.49
Support
First Support
230.61
Second Support
228.26
Third Support
226.17
Jagsonpal Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Tue Aug 11 2026 | 234.1 | 230.99 | -0.85% | 234.1 | 229.99 |
| Mon Aug 10 2026 | 231.5 | 232.97 | 0.76% | 234.78 | 230.35 |
| Fri Aug 07 2026 | 239.67 | 231.21 | -2.87% | 239.67 | 229 |
Jagsonpal Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-29 | Quarterly Results |
| 2026-04-27 | Audited Results & Final Dividend |
| 2026-03-12 | Buy Back of Shares |
| 2026-01-21 | Quarterly Results |
| 2025-11-03 | Quarterly Results |
| 2025-07-26 | Quarterly Results |
| 2025-05-06 | Audited Results & Final Dividend |
| 2025-01-22 | Quarterly Results |
| 2024-10-23 | Quarterly Results & Stock Split |
| 2024-08-07 | Quarterly Results |
Jagsonpal Pharmaceuticals News
Jagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Jagsonpal Pharmaceuticals announced that the audio recording of its Q1 FY27 Earnings Conference Call, held on July 30, 2026, is now accessible on the company's website. This provides investors access to discussions regarding the Q1 FY27 financial results.
Jul 30 2026 17:30:09
Jagsonpal Pharmaceuticals Ltd - 507789 - Corporate Action- Record Date: September 04, 2026
Jagsonpal Pharmaceuticals announced September 04, 2026, as the Record Date for its ₹4 dividend per equity share for FY26. The dividend is subject to shareholder approval at the upcoming AGM.
Jul 29 2026 18:36:55
Read More
Jagsonpal Pharmaceuticals Management
| Name | Position |
|---|---|
| Pratham Rawal | Company Secretary & Compliance Officer |
| Harsha Raghavan | Chairperson |
Jagsonpal Pharmaceuticals Similar Stocks
Windlas Biotech Ltd.
943.10
103.45 (12.32%)
Shalby Ltd.
161.67
-0.20 (0.12%)
Fermenta Biotech Ltd.
483.85
-64.10 (11.70%)
Amrutanjan Health Care Ltd.
533.75
6.40 (1.21%)
Suraksha Diagnostic Ltd.
258.25
-7.25 (2.73%)
GPT Healthcare Ltd.
160.51
3.37 (2.14%)
Syncom Formulations (India) Ltd.
14.53
0.19 (1.32%)
Q-Line Biotech Ltd.
537.85
2.05 (0.38%)
Jagsonpal Pharmaceuticals FAQs
The Buying Price of Jagsonpal Pharmaceuticals share is 230.99 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Jagsonpal Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Jagsonpal Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Jagsonpal Pharmaceuticals shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Jagsonpal Pharmaceuticals shares is 0. Useful to assess the stock's value relative to its book value.
To assess Jagsonpal Pharmaceuticals’s valuation compare Sector P/E, P/B which are 64.83 & 3.28 with sector averages, along with growth rates and financial metrics.
The Market Cap of Jagsonpal Pharmaceuticals is 1520.73 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Jagsonpal Pharmaceuticals share price is 272.50 & 155.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Jagsonpal Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in JAGSNPHARM
Or Download Choice FinX App
Invest in JAGSNPHARM
Account Opening Fee- AMC for 1st Year
- Auto Square Off Charges
- Call & Trade